Concepedia

Balaji Balasa

BB

Statistics

Publications

18

Citations

2K

H-Index

17

Active since

1993

Affiliations

Scripps Research Institute(Current)

NHS Blood and Transplant

Best Biotech

Memorial University of Newfoundland

University of Arkansas for Medical Sciences

Balaji Balasa is an author at Scripps Research Institute specializing in immunology, life sciences, and autoimmunity.

Publications per year

1993–2014

18

Publications

18

CS1, a Potential New Therapeutic Antibody Target for the Treatment of Multiple Myeloma

Eric D. Hsi, Roxanne Steinle, Balaji Balasa et al. · Clinical Cancer Research · 2008 · 560 citations · Full text

, , +15

CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice

Balaji Balasa, Troy Krahl, Gail Patstone et al. · The Journal of Immunology · 1997 · 244 citations · Full text

, , +17

Interferon γ (IFN-γ) Is Necessary for the Genesis of Acetylcholine Receptor–induced Clinical Experimental Autoimmune <i>Myasthenia gravis</i> in Mice

Balaji Balasa, Caishu Deng, Jae Lee et al. · The Journal of Experimental Medicine · 1997 · 182 citations · Full text

, , +16

Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse

Fu‐Dong Shi, Malin Flodström‐Tullberg, Balaji Balasa et al. · Proceedings of the National Academy of Sciences · 2001 · 173 citations · Full text

, , +17

Combinatorial efficacy of anti-CS1 monoclonal antibody elotuzumab (HuLuc63) and bortezomib against multiple myeloma

Frits van Rhee, Susann Szmania, Myles Dillon et al. · Molecular Cancer Therapeutics · 2009 · 173 citations · Full text

, , +17

1–5 of 18